Five-Year Outcomes With Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute Coronary Syndrome: A Subgroup Analysis of the BIOSCIENCE Trial

Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention

(2020) Mahesh V. Madhavan et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization

(2020) David E. Kandzari et al.   JACC-Cardiovascular Interventions

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

(2020) Jean-Philippe Collet et al.   EUROPEAN HEART JOURNAL

Five-year clinical outcomes and intracoronary imaging findings of the COMFORTABLE AMI trial: randomized comparison of biodegradable polymer-based biolimus-eluting stents with bare-metal stents in patients with acute ST-segment elevation myocardial infarction

(2019) Lorenz Räber et al.   EUROPEAN HEART JOURNAL

Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial

(2019) Juan F Iglesias et al.   LANCET

Newer Generation Ultra-Thin Strut Drug-Eluting Stents versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease: A Meta-Analysis of Randomized Trials

(2018) Sripal Bangalore et al.   CIRCULATION

Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients

(2018) Ariel Roguin et al.   Circulation-Cardiovascular Interventions

Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial

(2018) Thomas Pilgrim et al.   LANCET

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

(2017) Borja Ibanez et al.   EUROPEAN HEART JOURNAL

Orsiro cobalt-chromium sirolimus-eluting stent: present and future perspectives

(2017) Juan F. Iglesias et al.   Expert Review of Medical Devices

Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non–ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction

(2016) Thomas Pilgrim et al.   AMERICAN HEART JOURNAL

Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial

(2016) Manel Sabaté et al.   LANCET

Long-term outcomes of biodegradable versus durable polymer drug-eluting stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of individual patient data from three randomised trials

(2015) Antoinette de Waha et al.   EuroIntervention

Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention

(2015) Pascal Vranckx et al.   EuroIntervention

Randomized comparison of biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for percutaneous coronary revascularization: Rationale and design of the BIOSCIENCE trial

(2014) Thomas Pilgrim et al.   AMERICAN HEART JOURNAL

Differential healing response attributed to culprit lesions of patients with acute coronary syndromes and stable coronary artery after implantation of drug-eluting stents: An optical coherence tomography study

(2014) Lorenz Räber et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Stent Thrombosis in New-Generation Drug-Eluting Stents in Patients With STEMI Undergoing Primary PCI

(2014) Giovanna Sarno et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Outcomes With Various Drug-Eluting or Bare Metal Stents in Patients With ST-Segment–Elevation Myocardial Infarction

(2013) Sripal Bangalore et al.   Circulation-Cardiovascular Interventions

Histopathological comparison of biodegradable polymer and permanent polymer based sirolimus eluting stents in a porcine model of coronary stent implantation

(2012) Gerd Bayer et al.   THROMBOSIS AND HAEMOSTASIS

Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings

(2011) Kumaran Kolandaivelu et al.   CIRCULATION

Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity

(2010) Pascal Vranckx et al.   EuroIntervention

Delayed Arterial Healing and Increased Late Stent Thrombosis at Culprit Sites After Drug-Eluting Stent Placement for Acute Myocardial Infarction Patients

(2008) Gaku Nakazawa et al.   CIRCULATION